Huan Cai

Key Laboratory Of Clinical Laboratory Diagnostics
Chongqing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

A naked-eye biosensing system based on one-pot RPA-CRISPR/Cas12a driver G4-hemin self-assembly for Mycobacterium tuberculosis.

A naked-eye biosensing system based on one-pot RPA-CRISPR/Cas12a driver G4-hemin self-assembly for Mycobacterium tuberculosis.

Journal: Frontiers in chemistry
Published: May 22, 2025

Overcoming Immunotolerance in Chronic Hepatitis B: Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor-Based Immunotherapy in Achieving Hepatitis B Surface Antigen Seroclearance.

Overcoming Immunotolerance in Chronic Hepatitis B: Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor-Based Immunotherapy in Achieving Hepatitis B Surface Antigen Seroclearance.

Journal: MedComm
Published: March 10, 2025

Ultrasensitive Bi-Mode Lateral-Flow Assay via UCNPs-Based Host-Guest Assembly of Fluorescent-Colorimetric Nanoparticles.

Ultrasensitive Bi-Mode Lateral-Flow Assay via UCNPs-Based Host-Guest Assembly of Fluorescent-Colorimetric Nanoparticles.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 16, 2024

Flexible Scaffold Modulation of Spatial Structure and Function of Hierarchically Porous Nanoparticle@ZIF-8 Composites to Enhance Field Deployable Disease Diagnostics.

Flexible Scaffold Modulation of Spatial Structure and Function of Hierarchically Porous Nanoparticle@ZIF-8 Composites to Enhance Field Deployable Disease Diagnostics.

Journal: Small methods
Published: May 20, 2024

Pomegranate-Bionic Encapsulating Horseradish Peroxidase Using Dopamine Flexible Scaffold-Coated Multishell Porous ZIF-8 To Enhance Immunochromatographic Diagnosis.

Pomegranate-Bionic Encapsulating Horseradish Peroxidase Using Dopamine Flexible Scaffold-Coated Multishell Porous ZIF-8 To Enhance Immunochromatographic Diagnosis.

Journal: ACS nano
Published: May 17, 2023

Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B.

Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B.

Journal: Hepatology (Baltimore, Md.)
Published: October 13, 2022

Immunomodulatory and Antiviral Therapy Improved Functional Cure Rate in CHB Patients with High HBsAg Level Experienced NA.

Immunomodulatory and Antiviral Therapy Improved Functional Cure Rate in CHB Patients with High HBsAg Level Experienced NA.

Journal: Journal of clinical and translational hepatology
Published: August 25, 2022

Dynamic metabolic profiles for HBeAg seroconversion in chronic hepatitis B (CHB) patients by gas chromatography-mass spectrometry (GC-MS).

Dynamic metabolic profiles for HBeAg seroconversion in chronic hepatitis B (CHB) patients by gas chromatography-mass spectrometry (GC-MS).

Journal: Journal of pharmaceutical and biomedical analysis
Published: March 11, 2021

Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.

Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.

Journal: Journal of Zhejiang University. Science. B
Published: August 05, 2020

High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study.

High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study.

Journal: BMC infectious diseases
Published: July 24, 2020

Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.

Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.

Journal: The American journal of gastroenterology
Published: July 04, 2020

COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome.

COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome.

Journal: The Journal of infection
Published: May 22, 2020
Showing 1-12 of 23

Last Updated: 09/26/2026